Aspiriant LLC’s Dimensional US Targeted Value ETF DFAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
188,313
-2,927
-2% -$186K 0.34% 41
2025
Q4
$11.4M Sell
191,240
-701
-0.4% -$40.9K 0.33% 42
2025
Q3
$11.2M Sell
191,941
-1,927
-1% -$110K 0.34% 39
2025
Q2
$10.5M Buy
193,868
+3,727
+2% +$190K 0.33% 38
2025
Q1
$9.79M Buy
190,141
+17,080
+10% +$940K 0.34% 36
2024
Q4
$9.63M Buy
173,061
+1,313
+0.8% +$75.1K 0.35% 37
2024
Q3
$9.55M Sell
171,748
-841
-0.5% -$45.5K 0.36% 38
2024
Q2
$8.95M Sell
172,589
-106
-0.1% -$5.56K 0.36% 39
2024
Q1
$9.4M Sell
172,695
-6,106
-3% -$314K 0.39% 36
2023
Q4
$9.36M Sell
178,801
-2,058
-1% -$96.2K 0.42% 36
2023
Q3
$8.26M Sell
180,859
-2,085
-1% -$99K 0.42% 36
2023
Q2
$8.49M Sell
182,944
-989
-0.5% -$43.4K 0.43% 36
2023
Q1
$8.19M Buy
183,933
+10
+0% +$464 0.43% 37
2022
Q4
$8.08M Sell
183,923
-2,072
-1% -$91K 0.41% 35
2022
Q3
$7.25M Hold
185,995
0.35% 36
2022
Q2
$7.48M Sell
185,995
-2,772
-1% -$122K 0.36% 37
2022
Q1
$8.79M Buy
188,767
+2,213
+1% +$103K 0.48% 30
2021
Q4
$8.87M Sell
186,554
-11,563
-6% -$543K 0.47% 27
2021
Q3
$8.79M Sell
198,117
-7,126
-3% -$316K 0.52% 26
2021
Q2
$9.19M Buy
+205,243
New +$9.22M 0.52% 26

Other funds holding DFAT

Aspiriant LLC's DFAT Position: Q1 2026 in Review

Aspiriant LLC reduced its Dimensional US Targeted Value ETF (DFAT) stake by 1.5% in Q1 2026, selling an estimated $186K and leaving 188,313 shares worth $11.8M. The position accounts for 0.34% of the portfolio, ranked #41.

Aspiriant LLC first reported a position in DFAT in Q2 2021 and has held it in 20 quarters since. 816 funds tracked by Wall St. Rank hold DFAT as of Q1 2026.

  • Aspiriant LLC held 188,313 shares of Dimensional US Targeted Value ETF worth $11.8M as of Q1 2026.
  • Aspiriant LLC sold 2,927 Dimensional US Targeted Value ETF shares in Q1 2026, an estimated $186K.
  • Dimensional US Targeted Value ETF made up 0.34% of Aspiriant LLC's portfolio in Q1 2026, its #41 holding.
  • Aspiriant LLC first reported a position in Dimensional US Targeted Value ETF in Q2 2021 and has held it in 20 quarters since.
  • 816 funds tracked by Wall St. Rank held Dimensional US Targeted Value ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.